FDA “MORNING-AFTER PILL” DECISION “DEFIES SCIENCE AND LOGIC,” SAYS REP. MALONEY
WASHINGTON, DC - Late yesterday, the Food and Drug Administration (FDA) decided to go against the recommendation of an expert scientific panel and reject over-the-counter (OTC) status for the Plan B contraceptive, the so-called “Morning-After Pill.” In December of last year, the FDA Nonprescription Drugs and Reproductive Health Drugs Advisory Committees endorsed the idea of making Plan B available OTC by a 23-4 vote. Proponents of the OTC status, including Rep. Carolyn Maloney (NY-14) who has been outspoken in her criticism of the FDA, have been concerned that the FDA would bow to political pressure from the right wing.
Rep. Maloney said the following:
“This decision defies science and logic,” said Maloney. “The FDA exists to protect the health of Americans, not to do the political bidding of one group or another. The FDA’s apparent new policy to put political ideology above everything else is hazardous to our health. I worry for the health of Americans and, in particular, American women.”